Skip to content
Investment Visual
/
Backtest
Tools
Browse
Stocks
BMY
Financials
EBITDA
BMY
Bristol-Myers Squibb Company
Backtest
BMY
Overview
Returns
Financials
Holders
Insiders
Summary
Statements
Income
Revenue
Revenue by product
Revenue by region
Gross profit
Operating income
Net income
EPS
EBITDA
Cash flow
Balance sheet
Valuation
Shares and dividends
Costs
EBITDA
EBITDA, Q1 2012
$1.5B
YoY, Q1 2012
+4.3%
EBITDA
Value
YoY
5Y
10Y
Max
Value
YoY
5Y
10Y
Max
EBITDA by quarter
CSV
Period
Ended
EBITDA
YoY
Filing
Q1 2012
Q1 2012
Mar 31, 2012
$1.5B
+4.3%
10-Q, Apr 25, 2013
Q1 2011
Q1 2011
Mar 31, 2011
$1.5B
—
10-Q, Apr 26, 2012
More Bristol-Myers Squibb financials
Revenue
Revenue by product
Revenue by region
Gross profit
Operating income
Net income
EBITDA at other companies
DHR
Danaher Corporation
SYK
Stryker Corporation
CVS
CVS Health Corporation
MCK
McKesson Corporation
BSX
Boston Scientific Corporation
Tools
Return calculator